Abstract:With different types of nucleases, genome editing technologies have opened up the possibility for targeting and modifying specific gene sequences, which show potential applications in basic and applied aspects of biotechnology research. Zinc-finger nucleases（ZFNs） and transcription activator-like effector nucleases（TALENs） are artificial proteins generated by fusing a specific DNA-binding domain with a restriction enzyme FokI DNA-cleavage domain, which arise from their ability to customize the DNA-binding domain for recognition of targeting sequences and cleaving them by the FokI domain. However, the design and construction of such a system are time consuming,laborious and costly. Clustered regularly interspaced short palindromic repeats（CRISPR）/CRISPR associated（Cas）protein is a unique acquired immune system of bacteria or archaea. Since researchers constructed the CRISPR/Cas system for gene editing, its high efficiency has revolutionized a variety of fields such as life sciences, bioengineering, biomedicine, food, and agricultural sciences. However, the CRISPR/Cas system still has some challenges, such as offtarget effect and limited PAM site recognition range, which limit its further applications. In order to solve these problems, molecular engineering of Cas proteins has become an important strategy for developing and optimizing CRISPR/Cas systems. In this study, with CRISPR/Cas9 and CRISPR/Cas12a selected as representative examples for DNA-targeting Class II CRISPR/Cas systems, we focus on the optimization and modification methods, and progress of Cas9 and Cas12a proteins achieved within recent years, such as Cas protein engineering for improved on-target specificity and expanded PAM scopes, developing new functions using CRISPR/Cas systems as gene targeting tools, and introducing exogenous protein domains to regulate CRISPR/Cas functions. These studies have generated a series of high-specificity and high-precision CRISPR/Cas systems, which have greatly expanded their functions and scopes, and made important contributions to the wide-range applications of CRISPR/Cas systems.

Engineered transcription-associated Cas9 targeting in eukaryotic cells

Target residence of Cas9: challenges and opportunities in genome editing

Engineered CRISPR-Cas9 nuclease with expanded targeting space

Cas9-Based Tools For Targeted Genome Editing And Transcriptional Control

Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex

Targeted DNA integration in human cells without double-strand breaks using CRISPR RNA-guided transposases

Genome engineering using the CRISPR-Cas9 system

Targeted DNA integration in human cells without double-strand breaks using CRISPR-associated transposases

Engineered CRISPR-Cas9 nucleases with altered PAM specificities

DNA targeting by compact Cas9d and its resurrected ancestor

Protein Engineering of DNA Targeting Type Ⅱ CRISPR/Cas Systems

PAM-Flexible Genome Editing with an Engineered Chimeric Cas9.

Structure-guided engineering of type I-F CASTs for targeted gene insertion in human cells

Expanding the editable genome and CRISPR–Cas9 versatility using DNA cutting-free gene targeting based on in trans paired nicking

Structure and specificity of the RNA-guided endonuclease Cas9 during DNA interrogation, target binding and cleavage

CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes

A Targeted and Tuneable DNA Damage Tool Using CRISPR/Cas9

Screening DNA Aptamers That Control the DNA Cleavage, Homology-Directed Repair, and Transcriptional Regulation of the CRISPR-(d)Cas9 System.

Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants

Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system

Rapid two-step target capture ensures efficient CRISPR-Cas9-guided genome editing